1.25 / AMA PRA Category 1 Credit(s)TM
1.25 / CE for Nurses
1.25 / CE for Nurse Practitioners
This activity is provided by AKH Inc.
This activity is NOT supported by a commercial educational grant.
Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. Yet, the need for communication skills that address these issues is growing. This course will prepare participants to discuss the case management standards of practice and their application to end-of-life issues; identify the principles of pain management, palliative care, and symptom management near the end of life; review the concepts of death, loss, grief, bereavement, and coping strategies for patients and families; and apply the four levels of hospice care and the new Medicare hospice consultation rule.
This activity is intended to meet the needs of physicians, physician assistants, nurses, and nurse practitioners who participate in end-of-life patient care and family support.
Accredited Provider Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.
Margaret V. Clark, MS, RN, RRT-NPS – Medical Writer
Ms. Clark discloses no financial relationships with pharmaceutical or medical product manufacturers
Dorothy Caputo, MA, BSN, RN – Lead Nurse Planner
Ms. Caputo discloses no significant financial relationships with pharmaceutical or medical product manufacturers.
Bernadette Marie Makar, MSN, NP-C, APRN-C – Nurse Planner
Ms. Makar discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
AKH Inc.’s courses are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The courses are researched thoroughly, utilizing current literature and including practical experiences. AKH’s courses are not to be considered a diagnostic tool to replace professional advice or treatment. The courses serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational courses do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the courses. AKH further disclaims any responsibility for undetected errors, or from the reader’s misunderstanding of the course.
Copyright © 2013, AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.